TARA Buybacks
7 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–7; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Protara Therapeutics, Inc. | 2024-03-31 | Reported repurchase cash | $76,000.00 |
| Protara Therapeutics, Inc. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Protara Therapeutics, Inc. | 2023-03-31 | Reported repurchase cash | $64,000.00 |
| Protara Therapeutics, Inc. | 2022-12-31 | Reported repurchase cash | $0.00 |
| Protara Therapeutics, Inc. | 2022-03-31 | Reported repurchase cash | $72,000.00 |
| Protara Therapeutics, Inc. | 2021-12-31 | Reported repurchase cash | $0.00 |
| Protara Therapeutics, Inc. | 2021-03-31 | Reported repurchase cash | $228,000.00 |